Talk:Dasatinib

More recent article in NEJM (2010)
http://www.nejm.org/doi/full/10.1056/NEJMoa1002315 Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia June 17, 2010 Kantarjian H., Shah N.P., Hochhaus A., et al.   N Engl J Med 2010; 362:2260-2270 Free Full Text

There are also quite a few more articles. --Nbauman (talk) 01:01, 6 November 2014 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified one external link on Dasatinib. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive https://web.archive.org/web/20070711095941/http://www.emea.europa.eu/humandocs/PDFs/EPAR/sprycel/H-709-PI-en.pdf to http://www.emea.europa.eu/humandocs/PDFs/EPAR/sprycel/H-709-PI-en.pdf

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Cheers.— InternetArchiveBot  (Report bug) 04:51, 5 September 2017 (UTC)

It looks that 2 points mentioned in said article are same to me
"newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukaemia in chronic phase (Ph+ CML CP) or Ph+ CML CP resistant or intolerant to prior therapy including imatinib." and "newly diagnosed Ph+ CML in chronic phase (Ph+ CML-CP) or Ph+ CML-CP resistant or intolerant to prior therapy including imatinib.". Can anybody help clarify? Thanks for you kind attention. ThomasYehYeh (talk) 07:39, 20 March 2024 (UTC)